In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both ...

High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...

For years, scientists studying brain aging have focused on proteins and DNA. But what if a crucial piece of the puzzlehas ...

Scientists performed a first-ever clinical test of the therapy avapritinib in pediatric patients with high-grade glioma. They ...

Scientists at UCLA have discovered a potential new way to treat glioblastoma, the most aggressive type of brain cancer. Their ...

A protein called HER3, which is present on the blood–brain barrier, helps the tumour-invading protein cross from the ...

High-grade glioma, a difficult-to-treat and aggressive form of pediatric and adult brain cancer, responded to FDA-approved avapritinib. | Drug Discovery And Development ...

Novel HER2 therapies show strong intracranial efficacy, enabling systemic treatment over local therapy for small, ...

A new therapy offers hope for treating pediatric brain tumors, targeting cancer cells while minimizing side effects for young ...

An international team of clinical collaborators, led by physician scientists from Dana-Farber Cancer Institute, performed a first-ever clinical test of the targeted therapy avapritinib in pediatric ...